2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a heterocyclic amine derived from cooked meat that is a mammary gland carcinogen in rats. A carcinogenic doseregimen of PhIP (75 mg/kg, p.o., 10 doses, once per day) was administered to 43-day old female Sprague-Dawley rats, and the rats were then placed on a defined high fat (23.5% corn oil) or low fat (5% corn oil) diet for up to 6 weeks. At various times after carcinogen and diet, and prior to carcinogenesis, we examined the percentage of proliferating cells in terminal end bud (TEB) epithelial structures of the rat mammary gland by proliferating cell nuclear antigen staining, mammary gland architecture by whole mounting, and PhIP-DNA adduct levels in mammary epithelial cells by the 32 P-post-labeling assay. Immediately after dosing, the percentage of proliferating epithelial cells in TEBs was significantly higher in PhIP-treated rats than in control rats receiving vehicle only [7.5 ⍨ 0.9% (n ⍧ 99) versus 4.2 ⍨ 0.6% (n ⍧ 127), respectively]. The mammary glands of PhIP-treated rats showed a significantly lower density of alveolar buds (ABs) and a higher density of TEBs than control rats, which suggests that PhIP exposure partially inhibited the normal glandular differentiation of TEBs to ABs. After 6 weeks on the diet, proliferation in TEBs was statistically higher in rats given PhIP plus a high fat diet than in rats given vehicle plus a low fat diet. The mammary glands from rats on a high fat diet also showed a statistically higher density of TEBs when compared with rats on a low fat diet [2.08 ⍨ 0.34% versus 1.04 ⍨ 0.20%, respectively (n ⍧ 6)]. PhIP-DNA adduct levels were relatively high in mammary epithelial cells of treated rats. At 3 h after the last dose of PhIP, DNA adduct levels [relative adduct labeling (RAL)⍥10 7 , mean Ϯ SE] were 10.5 ⍨ 1.7 (n ⍧ 8) and 0.9 ⍨ 0.2 (n ⍧ 7) in epithelial cells isolated from mammary gland and in the liver, respectively. DNA adduct removal rates from the mammary gland were not different between rats on the high fat and low fat diets. Adducts were still detected after 6 weeks on either diet. Thus, events that occurred prior to neoplasia in the mammary glands of PhIP-treated rats include formation of PhIP-DNA adducts at relatively high levels, and enhanced proliferation in TEBs (putative sites *Abbreviations: AB, alveolar bud; DAB, diaminobenzidine; DMBA, 7, anthracene; HCA, heterocyclic amine; IDP, intraductal proliferation; Ig, immunoglobulin; PCNA, proliferating cell nuclear antigen; PhIP, 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine; TD, terminal duct; TEB, terminal end bud.
Introduction
It is generally recognized that diet and lifestyle influence human breast cancer risk (1) . Breast cancer rates are relatively high in the Western world and appear to be partly associated with Western-style dietary habits (see ref. 2 for review). The possibility that the Western diet harbors specific carcinogens that are causative agents in human breast cancer has been raised (3) (4) (5) (6) (7) (8) (9) . Cooked meat, a staple of the Western diet, contains potent mutagens and rodent carcinogens belonging to the heterocyclic amine (HCA*) family of compounds (4, (10) (11) (12) (13) (14) (15) (16) . One of the HCAs, 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP), has been shown to be a mammary gland carcinogen in rats under a variety of dosage and experimental conditions (17) (18) (19) (20) (21) (22) . This rat mammary gland carcinogen is currently acknowledged as the principle carcinogenic HCA found in the Western diet (13, 15) . It is produced in meat during cooking by the reaction of an amino acid with creatine, precursors found in muscle meats (12, 14) . Originally isolated from fried hamburger, PhIP has now been found in a variety of fried, broiled or barbecued meats including beef, pork and chicken (12, (14) (15) (16) .
Studies in our laboratory reported that PhIP rapidly induces mammary gland tumors in female Sprague-Dawley rats when administered orally during mammary gland development according to a modified Huggins' method for rat mammary tumor induction (19, 23) . In addition, the incidence of PhIPinduced rat mammary gland carcinomas is increased when rats were given a high fat diet after dosing with PhIP (19) . Using the potent experimental mammary gland carcinogen 7,12-dimethylbenz[a]anthracene (DMBA), previous studies have shown that the rat mammary gland is most susceptible to chemical carcinogenesis during the period of active post-natal growth and development that occurs roughly between 30 and 55 days of age, with susceptibility declining with maturation (23) (24) (25) (26) (27) (28) . The sensitivity of the rat mammary gland to chemical carcinogenesis has been shown to correlate with the presence of mammary gland terminal end buds (TEBs) (25, 26) . During mammary gland development, TEBs are actively growing ductal structures that differentiate to alveolar buds (ABs) and then to lobules (28) (29) (30) (31) . Some TEBs also regress to terminal ducts (TDs) that remain until further differentiation during pregnancy and lactation (29) . During the early stages of DMBA-induced mammary gland carcinogenesis, Russo and Russo found that the differentiation of TEBs to ABs is inhibited and that TEBs and TDs give rise to intraductal proliferations (IDPs) (25) . IDPs appear to serve as preneoplastic lesions that may ultimately progress to intraductal carcinomas (24) (25) (26) (27) (28) (29) (30) (31) .
It is not yet known what developmental alterations occur prior to carcinogenesis in the mammary gland of PhIP-treated rats. In fact, little is known about the early events involved in PhIP-induced mammary gland carcinogenesis. Previous studies have shown that PhIP forms DNA adducts in mammary gland epithelial cells of rats, which may initiate the process of carcinogenesis (32) . The formation of PhIP-DNA adducts is associated with the metabolic activation of PhIP to the N-hydroxylamine and N-acetoxy metabolites (32) (33) (34) . Metabolism by phase II O-acetylation of the N-hydroxylamine metabolite of PhIP is relatively high in the mammary gland and has been suggested to play an important role in the formation of PhIP-DNA adducts in this target tissue (32) .
In our model, a high fat diet is a strong promoter of PhIP-induced rat mammary gland carcinogenesis (19) . The mechanisms of promotion by a high fat diet are not entirely understood, but may include an increase in circulating estrogens or other mammotrophic hormones, alterations in hormone responsiveness, and effects on the levels of certain fatty acids that act as secondary messengers or modifiers of signal transduction pathways (2, (35) (36) (37) . A high fat diet also appears to alter mammary gland development (37, 38) . Whether the promotional influence of dietary fat on PhIP carcinogenesis is reflected by a modification of certain PhIP-induced early alterations in the mammary gland has not yet been investigated.
In the current study, we used our previously described rat mammary gland model with PhIP and a high fat diet (19) to examine several of the early events that occur in the mammary gland prior to carcinogenesis. In light of the role of TEBs in mammary gland susceptibility to carcinogenesis, the effect of PhIP and a high fat diet on TEB proliferation was studied. In addition, the effects of the carcinogen and diet on mammary gland differentiation were examined by whole mounting the gland. To further investigate how dietary fat might enhance PhIP-induced mammary gland carcinogenesis, PhIP-DNA adduct removal from the mammary gland was compared in rats on high fat and low fat diets.
Materials and methods

Animals and treatment
Female Sprague-Dawley rats, 35 days old, were obtained from the NIH animal supply (Animal Production Area, FCRDC, Frederick, MD) and maintained on NIH Lab Chow. Throughout the study, rats were given food and water ad libitum and housed in a NIH animal facility on a 12 h lightdark cycle. At 43 days of age, rats received 10 oral doses of PhIP (75 mg/kg body wt and 5 ml corn oil/kg body wt) once per day as described (19) . Control rats were given an identical treatment with the corn oil vehicle only. After the final dose of PhIP or corn oil, rats were either killed after 3 h or placed on a defined high fat diet (23.5% corn oil) or defined low fat diet (5% corn oil) for various times up to 6 weeks before being killed. The diets were identical to those reported previously (19) . Tumor incidence has been shown to be higher in PhIP-treated rats on the high fat diet than those on the low fat diet (19, E.G.Snyderwine et al., submitted for publication).
P-post-labeling analysis of PhIP-DNA adducts
Liver and inguinal/abdominal mammary glands (numbers 4-6) were excised at necropsy. Mammary epithelial cells were isolated from mammary glands (pooled from 2-3 rats) as described previously (32) . Liver and mammary epithelial cells were stored at -70°C until DNA isolation. DNA was isolated from epithelial cells and liver using a standard phenol extraction procedure. The intensification (ATP-deficient) method of Randerath et al. (39) , described in detail for the analysis of PhIP-DNA adducts (40) , was used to resolve PhIP-DNA adducts as [ 32 P]ATP-labeled bis-phosphonucleotide adduct 'fingerprints' on autoradiograms after chromatography. Adduct levels were 1210 quantified by Cerenkov counting and relative adduct labeling (RAL) values calculated using the previously determined intensification factors (40) .
Rat mammary gland proliferation
Proliferating cell nuclear antigen (PCNA) staining, used as a marker of proliferation, was carried out essentially as described previously (41) . Rat mammary glands numbers 4-6 were excised and fixed in 10% buffered formalin before being embedded in paraffin. Sections (5 µm) were cut and mounted on poly(L-lysine)-coated glass slides. The sections were deparaffinized and rehydrated prior to incubation in periodic acid to inhibit endogenous peroxide activity. Non-specific binding of immunoglobulin G (IgG) was suppressed by incubating the sections in 1% horse serum. Next, the sections were incubated with PCNA antibody (PC10; Dako, Copenhagen, Denmark) and then with biotinylated anti-mouse IgG (Vectastain ABC kit; Vector Lab, Burlingame, CA). This was followed sequentially by a 30-min incubation with Vectastain ABC reagent, staining with diaminobenzidine (DAB Chromagen tablets; Dako) and counterstaining with hematoxylin. The PCNAstained epithelial cells and the total number of epithelial cells were counted in each TEB identified in the mammary gland section. The number of stained cells per total cells (multiplied by 100) represented the percentage of proliferating cells or PCNA index in each TEB. TEBs were identified according to the criteria of Russo et al. as glandular structures displaying at least three epithelial cell layers around a central lumen (30) .
Mammary gland whole mounting and analysis of structural development
The whole mount preparation of the rat mammary gland was carried out according to the method of Russo et al. (24) . Briefly, the skin pelt with attached mammary glands was removed from the rat, stretched and pinned onto a board, and fixed in 10% buffered formalin. The fourth mammary gland was dissected from the skin, defatted in acetone, hydrated in ethanol, and stained with toluidine blue. After washing in distilled water and alcohol, the stain was fixed in 4% ammonium molybdate and then washed in distilled water. Next, the gland was dehydrated in increasing concentrations of ethanol and stored in xylene until microdissection and mounting. Surrounding muscle and connective tissue was removed from the gland by microdissection under a Zeiss Stemi 2000 stereomicroscope (Carl Zeiss, Thornwood, NY), and the gland was mounted on a glass slide. Mammary gland structures including TEBs, terminal ducts (TDs), ABs, and lobules identified by size and shape according to the criteria of Russo et al. (25, 26, 30) , were counted in the outer 2 mm of zone C of the mammary gland. Identification and counting of the structures was aided by an image analysis system that consisted of MTI DC-330 3CCD color camera (DAGE-MTI, Michigan City, IN) attached to the stereomicroscope and a Pentium computer equipped with Zeiss Image (version 3.0) software. All measurements were carried out at ϫ32 after calibration with a micrometer.
Statistical analysis
Data were analyzed by Student's t-test, Mann-Whitney rank sum test, oneway ANOVA or two-way ANOVA using the statistical package SigmaStat (version 2.01, Jandel Scientific Software, San Rafael, CA).
Results
At 3 h after the rats received the 10th oral dose of PhIP, PhIP-DNA adduct levels (mean RALϫ10 7 Ϯ SE) in mammary gland and liver were 10.5 Ϯ 1.7 (8 mammary epithelial cell preparations each from 2-3 rats) and 0.9 Ϯ 0.2 (7 livers). Adduct levels were also examined in PhIP-treated rats placed on the high and low fat diets for 2, 7, 14 and 42 days after dosing ( Figure 1A and B) . In rats on either diet, PhIP-DNA adduct levels in the mammary gland were not statistically different at 2 days from those at 3 h after dosing. Irrespective of diet, PhIP-DNA adduct levels in the mammary gland epithelial cells declined rapidly from 2 to 7 days on the diet and more slowly from 7 to 14 days ( Figure 1A ). Very little additional decline in PhIP-DNA adduct levels in the mammary gland was observed from 14 to 42 days on either diet. At 42 days, PhIP-DNA adduct levels were 0.7-0.8 (RALϫ10 7 ) in the mammary gland epithelial cells isolated from rats on either diet. At each time point examined, no statistical difference in PhIP-DNA adduct levels was found between the high and low fat diet groups.
Adduct levels in the liver of rats on the high fat diet decreased steadily from 2 to 14 days after dosing ( Figure 1B ). At 7 days after dosing, hepatic PhIP-DNA adduct levels were significantly higher in rats on the low fat diet (Student's t-test, P Ͻ 0.05), which suggests that DNA adduct removal from the liver was faster in rats on the high fat diet. After 42 days on diet, however, hepatic PhIP-DNA adduct levels were similar in both diet groups. Comparing adduct levels between liver and mammary gland indicates that PhIP-DNA adduct levels were 12-to 15-fold higher in mammary gland than liver at 3 h and 2 days after dosing, and 4-to 6-fold higher in the mammary gland at 7, 14 or 42 days after dosing, irrespective of diet. The PhIP-DNA adduct profiles were identical in both organs (data not shown). The 32 P-post-labeling profile for PhIP-DNA adducts in the mammary gland of PhIP-treated rats have been reported previously (32) . Three guanine adducts, one identified as the C8-guanine adduct, were found in both tissues. In either tissue and diet, there did not appear to be a selective removal of any of the three guanine adduct spots. As TEBs are considered to be a putative site of origin of rat mammary gland carcinomas (24) (25) (26) (27) (28) (29) (30) (31) , the effect of PhIP on the percentage of proliferating cells in TEBs was assessed by PCNA immunohistochemistry. On average, the percentage of proliferating cells in the TEBs of mammary glands from rats exposed to PhIP was nearly 2-fold higher than that observed in rats given vehicle only (P Ͻ 0.05, one-way ANOVA on ranks) (Figure 2) . A greater percentage of TEBs were more proliferative in mammary glands from PhIP-treated rats than in mammary gland from control rats, and highly proliferative TEBs were relatively rare in the mammary gland of vehicle control rats. Specifically, whereas just 13% of the TEBs in Fig. 2 . Proliferation in TEB structures in mammary glands of rats treated with PhIP or vehicle only. Rats were killed 3 h after the final dose of PhIP. Proliferation is expressed as the mean percentage (ϮSE) of PCNA-stained cells per total cells in each TEB. TEBs were identified histologically as glandular structures having 3-6 layers of epithelium. n ϭ 127 and 99 TEBs in control and PhIP-treated rats, respectively. Seven rats were examined in each group. *Statistically different (P Ͻ 0.05, one-way ANOVA on ranks).
Fig. 3. Proliferation in TEB structures in mammary glands of rats treated
with PhIP or vehicle only and placed on either a high fat or low fat diet for 6 weeks. Proliferation is expressed as the mean percentage (ϮSE) of PCNA-stained cells per total cells in each TEB. TEBs were identified histologically as glandular structures having 3-6 layers of epithelium. n ϭ 144 TEBs in control and PhIP-treated rats on high fat diet and n ϭ184 and 104 in control and PhIP-treated rats on a low fat diet, respectively. Twelve to 14 rats were examined in each group. Bars with different letters are statistically different (P Ͻ 0.05, one-way ANOVA on ranks with pairwise multiple comparison carried out by the Dunn's method).
glands from vehicle control rats had a PCNA index Ͼ 10%, 36% of the TEBs in glands from PhIP-treated rats had a PCNA index Ͼ 10%.
To evaluate the effect of diet on TEB proliferation, proliferation was measured in TEBs from PhIP-treated and vehicle control rats maintained on the high fat and low fat diets for 42 days (6 weeks) after dosing ( Figure 3) . A two-way ANOVA revealed a statistically significant effect of the high fat diet on TEB proliferation (P Ͻ 0.05). The percentage of proliferating cells was 1.5-fold higher in PhIP-treated rats on the high fat diet compared with PhIP-treated rats on a low fat diet, and it was 1.75-fold higher in control rats on a high fat diet compared with vehicle control rats on a low fat diet. The highest percentage of proliferating cells was found in PhIP-treated rats on a high fat diet and the lowest was found in vehicle control rats on a low fat diet, which suggests that PhIP combined with dietary fat provided the greatest stimulus for proliferation (P Ͻ 0.05, one-way ANOVA on ranks). It is notable that the PCNA index in TEBs was 66% lower in rats on the diet for 6 weeks than in rats killed before the diet (compare control with control on low fat diet, Figures 2 and 3) . The ages of the animals before and after diet are 54 and 96 days in Figures 2  and 3 , respectively. A previous study showed that the rate of proliferation in TEBs declines as rats mature (26) , and the decline observed in our study is therefore likely to be associated with normal maturation of the gland.
Whole mount analysis was carried out to examine the effect of PhIP and diet on the architecture and development of the rat mammary gland. A view of the various structures observed by whole mounting the mammary glands of PhIP-treated rats is provided in Figure 4A -D. Mammary glands from rats killed 3 h after PhIP or vehicle (54-day-old rats) consisted primarily of TEBs, TDs and ABs. Very little lobular development was found in animals of this age group. Differences, however, were observed between the glands isolated from PhIP-treated and control rats. The density of TEBs (number of TEBs/mm 2 ) was 1.5-fold higher in PhIP-treated rats than in vehicle control rats (P Ͻ 0.05, Student's t-test) ( Figure 5 ). In addition, the density of ABs in the mammary gland was~2-fold lower in PhIP-treated rats than in the vehicle controls (P Ͻ 0.05, Student's t-test). Lobular development was low to non-detectable in the mammary glands from vehicle control and PhIPtreated rats.
After 6 weeks on either the high fat or low fat diet, lobular development was similar in PhIP-treated and control rats and ranged from~0.63 to 1.01 structures/mm 2 ( Figure 6 ). Statistical differences in AB levels were not observed at this time point (P Ͼ 0.05, two-way ANOVA). In addition, there were no statistical differences in the densities of TDs between any of the four groups. There was, however, a statistically significant effect of the high fat diet on the density of TEBs irrespective of PhIP treatment (two-way ANOVA, P Ͻ 0.05). The mean density of TEBs Ϯ SE was 2.08 Ϯ 0.34 (n ϭ 6) and 1.04 Ϯ 0.20 (n ϭ 6) in all rats (PhIP plus control) on the high fat diet and low fat diet, respectively.
Discussion
PhIP is a well-recognized rat mammary gland carcinogen among the family of HCAs. However, the mechanisms of mammary gland carcinogenicity of PhIP are still poorly understood. In the current study, several alterations in the mammary glands of PhIP-treated rats were observed that may be germane to the targeting of PhIP to the mammary gland. First, relatively high DNA adduct levels are sustained in the mammary epithelial cells of the gland. Indeed, the adduct levels are upwards of 15-fold higher than those found in the liver, an organ that is not a target site of PhIP carcinogenesis (Figure 1 ). These adducts were also detected in the mammary gland epithelial cells of rats for 6 weeks after dosing, irrespective of diet, suggesting that there might be ample opportunity for these adducts to induce mutations. In addition to high DNA adduct levels, PhIP exposure is associated with an enhanced proliferation in the TEBs (Figures 2 and 3) , which are structures in the developing mammary gland that appear to be the site of origin of carcinomas (25, 26) . Enhanced proliferation in TEBs is also observed after exposure to the potent mammary gland carcinogens N-nitroso-N-methylurea and DMBA (24, 42) , which further supports the notion that elevated proliferation in these glandular structures is relevant for mammary gland carcinogenesis. Hypothetically, the increase in proliferation in TEBs may facilitate the fixation of mutations from PhIP-DNA adducts and enhance the likelihood of initiating carcinogenesis.
Another effect of PhIP on the rat mammary gland is an inhibition of TEB differentiation. The inhibition of differentiation in PhIP-treated rats is reflected in a statistically higher level of TEBs and accordingly, a statistically lower level of the more differentiated AB structures ( Figure 5 ). Since TEBs are more sensitive than ABs to chemical-induced mammary gland carcinogenesis (28) , extending the duration of TEBs in the mammary gland may increase the opportunity for induction of neoplasia by PhIP. PhIP-DNA adduct levels are also relatively high at the time when the inhibition of mammary gland differentiation was observed (i.e. immediately after dosing with PhIP). The concordance of these two events, high adduct levels and inhibition of differentiation, may further enhance the likelihood of initiation by PhIP. The mechanisms involved in the inhibition of TEB differentiation by PhIP are not known. It is tempting to speculate that exposure to the carcinogenic-dose regimen of PhIP results in the stimulation of stem-cell like epithelial cells harbored in TEBs that have qualities of preneoplastic cells.
The effect of PhIP on mammary gland structure and differentiation was less severe and much less prolonged than the effect reported previously with DMBA (25) . Russo and Russo (25) reported a marked inhibition of TEB differentiation to ABs, as well as to lobules and TDs after DMBA exposure. In addition, the inhibitory effects on differentiated structures and elevated levels of TEBs were observed for at least 6 weeks after DMBA treatment. In contrast, 6 weeks after PhIP exposure there were no differences in the densities of TEBs, TDs, AB or lobules within each diet group ( Figure 6 ). (We did, however, observe TEB levels to be affected by dietary fat, as discussed further below.) The difference between the effects of the two carcinogens on the mammary gland structure may relate to the difference in their carcinogenic potencies in rats. A single 10 or 15 mg dose of DMBA (roughly 50-100 mg/kg, p.o.) is sufficient to induce a 100% incidence of mammary gland tumors, whereas a cumulative dose of 750 mg PhIP/kg induces an~50% tumor incidence in rats on a high fat diet (19,23,43 , E.G.Snyderwine et al., submitted for publication). The differences between the two carcinogens further supports the notion raised previously (24, 28, 29) that specific structural alterations in the mammary gland are relevant for carcinogenesis and targeting of carcinogens to the gland. Thus, it appears that the more potent a mammary gland carcinogen, the greater is its inhibitory effect on TEB differentiation.
High fat diets rich in linoleic acid are well recognized to promote rat mammary gland chemical carcinogenesis (43) (44) (45) (46) , and in our rat model, a linoleic acid-rich high fat diet enhances PhIP-induced rat mammary gland carcinogenesis (19, E.G.Snyderwine et al., submitted for publication). The current study shows that consumption of this high fat diet was associated with specific preneoplastic alterations in the mammary glands of PhIP-treated rats. After 6 weeks on defined high fat or low fat diet, epithelial cell proliferation in TEBs of the mammary gland was higher in rats on a high fat diet than in rats on a low fat diet (Figure 3 ). These findings are in agreement with studies carried out in mice that reported that certain high fat diets increase the proliferation in ductal epithelial cells of the mammary gland (47) (48) (49) (50) . Unique to our study was the finding that a high fat diet acts in concert with a chemical carcinogen to sustain proliferation in the TEB epithelial cells of the rat mammary gland. This was shown by the result that epithelial cell proliferation was~2-fold higher in TEBs from PhIP-treated rats on a high fat diet than in TEBs from vehicle control rats on a low fat diet (Figure 3) .
Dietary fat intake has been reported to affect the development of the mammary gland when rats are weaned onto diet (38) . In addition, maternal dietary fat intake has also been reported to alter mammary gland development in female offspring (37) . Therefore, we examined the effect of diet on the mammary gland development in PhIP-treated rats. In our model, placing the rats on a high fat diet for 6 weeks after dosing with PhIP or vehicle increased the level of TEBs relative to the level observed in the mammary gland of rats on a low fat diet. Thus, the consequence of placing rats on a high fat diet is to increase both the density and proliferation of TEBs during the period of time when PhIP-DNA adducts are present in the mammary epithelial cells. It is interesting that the high fat diet did not alter PhIP-DNA adduct removal rates from the epithelial cells of the mammary gland (Figure 1 ). Thus the enhanced proliferation and effects on mammary gland differentiation may be potentially more relevant for the mechanism of dietary fat promotion than is the effect of diet on DNA adduct levels. Speculatively, the promotional effect of a high fat diet may in part involve a further fixation of PhIP-DNA adductinduced mutations through an enhanced proliferative stimulus rather than by an inhibition of DNA adduct repair processes.
The HCA PhIP is a genotoxic carcinogen that is well recognized for its ability to form DNA adducts in target and non-target tissues of experimental animals (34, 40, 51) . This report is the first to indicate that PhIP has an effect on mammary gland development and proliferation in ductal epithelial cells. Therefore in addition to DNA adduct formation, PhIP has several effects on the mammary gland that may be relevant for carcinogenesis. It is not yet known if the proliferative and developmental effects of PhIP on the gland are associated with the genotoxic effects of PhIP-DNA adducts or to other properties of the carcinogen that facilitate targeting to the gland. Further studies are still required to address this issue.
